Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Non-Current Assets: 2009-2024

Historic Non-Current Assets for Rockwell Medical (RMTI) over the last 16 years, with Dec 2024 value amounting to $22.2 million.

  • Rockwell Medical's Non-Current Assets fell 12.66% to $20.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.0 million, marking a year-over-year decrease of 12.66%. This contributed to the annual value of $22.2 million for FY2024, which is 5.23% down from last year.
  • Rockwell Medical's Non-Current Assets amounted to $22.2 million in FY2024, which was down 5.23% from $23.4 million recorded in FY2023.
  • Rockwell Medical's 5-year Non-Current Assets high stood at $23.4 million for FY2023, and its period low was $8.3 million during FY2020.
  • Over the past 3 years, Rockwell Medical's median Non-Current Assets value was $22.2 million (recorded in 2024), while the average stood at $19.0 million.
  • As far as peak fluctuations go, Rockwell Medical's Non-Current Assets dropped by 14.76% in 2022, and later soared by 106.65% in 2023.
  • Over the past 5 years, Rockwell Medical's Non-Current Assets (Yearly) stood at $8.3 million in 2020, then spiked by 60.48% to $13.3 million in 2021, then fell by 14.76% to $11.3 million in 2022, then soared by 106.65% to $23.4 million in 2023, then decreased by 5.23% to $22.2 million in 2024.